Huaihua Zhenghao Pharmaceutical

Huaihua Zhenghao Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and commercialization of traditional Chinese patent medicines (TCM). Established in 1997 and headquartered in Huaihua, Hunan Province, the company operates a modern manufacturing facility producing nine major dosage forms, including tablets, pills, syrups, and granules. Its core product portfolio focuses on gynecological, pediatric, cardiovascular, and respiratory therapies, with key products such as Jingangteng Syrup, Jingangteng Pills, Kanggongyan Tablets, and Guipi Wan. Acquired by Hunan Detian Investment Group in 2013, Huaihua Zhenghao Pharmaceutical continues to leverage local herbal resources and collaborate with academic institutions like Hunan University of Chinese Medicine to advance modernized TCM.